Overview

Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

Status:
Completed
Trial end date:
2019-09-14
Target enrollment:
Participant gender:
Summary
Transition to Ferric Citrate among Hemodialysis and Peritoneal Dialysis Patients: A Phase 4 "Real World" Experience Study from Kaiser Permanente Southern California
Phase:
Phase 4
Details
Lead Sponsor:
Kaiser Permanente
Collaborator:
Keryx Biopharmaceuticals
Treatments:
Citric Acid
Ferric Compounds